223 related articles for article (PubMed ID: 33371334)
1. Apremilast Microemulsion as Topical Therapy for Local Inflammation: Design, Characterization and Efficacy Evaluation.
Sarango-Granda P; Silva-Abreu M; Calpena AC; Halbaut L; Fábrega MJ; Rodríguez-Lagunas MJ; Díaz-Garrido N; Badia J; Espinoza LC
Pharmaceuticals (Basel); 2020 Dec; 13(12):. PubMed ID: 33371334
[TBL] [Abstract][Full Text] [Related]
2. Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis.
Schafer PH; Parton A; Gandhi AK; Capone L; Adams M; Wu L; Bartlett JB; Loveland MA; Gilhar A; Cheung YF; Baillie GS; Houslay MD; Man HW; Muller GW; Stirling DI
Br J Pharmacol; 2010 Feb; 159(4):842-55. PubMed ID: 20050849
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Apremilast Gels in Mouse Model of Imiquimod-Induced Psoriasis Skin Inflammation.
Silva-Abreu M; Sosa L; Espinoza LC; Fábrega MJ; Rodríguez-Lagunas MJ; Mallandrich M; Calpena AC; Garduño-Ramírez ML; Rincón M
Pharmaceutics; 2023 Sep; 15(10):. PubMed ID: 37896163
[TBL] [Abstract][Full Text] [Related]
4. Topical Nanostructured Lipid Carrier Based Hydrogel of Mometasone Furoate for the Treatment of Psoriasis.
Kaur N; Sharma K; Bedi N
Pharm Nanotechnol; 2018; 6(2):133-143. PubMed ID: 29788899
[TBL] [Abstract][Full Text] [Related]
5. Harnessing the potential of fatty Acid-Surfactant-Based micellar gel for enhanced topical delivery of Apremilast in psoriasis treatment.
Sontakke A; Dighe S; Sharma R; Yadav V; Jain S
Int J Pharm; 2024 Apr; 655():124026. PubMed ID: 38518872
[TBL] [Abstract][Full Text] [Related]
6. Apremilast inhibits inflammatory osteoclastogenesis.
Degboé Y; Sunzini F; Sood S; Bozec A; Sokolova MV; Zekovic A; McInnes IB; Schett G; Goodyear CS
Rheumatology (Oxford); 2021 Dec; 61(1):452-461. PubMed ID: 33788924
[TBL] [Abstract][Full Text] [Related]
7. Dual roles of TPGS based microemulsion for tacrolimus: Enhancing the percutaneous delivery and anti-psoriatic efficacy.
Wan T; Pan J; Long Y; Yu K; Wang Y; Pan W; Ruan W; Qin M; Wu C; Xu Y
Int J Pharm; 2017 Aug; 528(1-2):511-523. PubMed ID: 28629978
[TBL] [Abstract][Full Text] [Related]
8. Design and dermatokinetic evaluation of Apremilast loaded nanostructured lipid carriers embedded gel for topical delivery: A potential approach for improved permeation and prolong skin deposition.
Rapalli VK; Sharma S; Roy A; Singhvi G
Colloids Surf B Biointerfaces; 2021 Oct; 206():111945. PubMed ID: 34216849
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms Underlying the Clinical Effects of Apremilast for Psoriasis.
Pincelli C; Schafer PH; French LE; Augustin M; Krueger JG
J Drugs Dermatol; 2018 Aug; 17(8):835-840. PubMed ID: 30124722
[TBL] [Abstract][Full Text] [Related]
10. Apremilast increases IL-10-producing regulatory B cells and decreases proinflammatory T cells and innate cells in psoriatic arthritis and psoriasis.
Mavropoulos A; Zafiriou E; Simopoulou T; Brotis AG; Liaskos C; Roussaki-Schulze A; Katsiari CG; Bogdanos DP; Sakkas LI
Rheumatology (Oxford); 2019 Dec; 58(12):2240-2250. PubMed ID: 31209492
[TBL] [Abstract][Full Text] [Related]
11. Apremilast: A Review in Psoriasis and Psoriatic Arthritis.
Keating GM
Drugs; 2017 Mar; 77(4):459-472. PubMed ID: 28213862
[TBL] [Abstract][Full Text] [Related]
12. Formulation, characterization, and in vitro/ex vivo evaluation of quercetin-loaded microemulsion for topical application.
Kajbafvala A; Salabat A; Salimi A
Pharm Dev Technol; 2018 Oct; 23(8):741-750. PubMed ID: 27871215
[TBL] [Abstract][Full Text] [Related]
13. Selective Phosphodiesterase Inhibitors for Psoriasis: Focus on Apremilast.
Gooderham M; Papp K
BioDrugs; 2015 Oct; 29(5):327-39. PubMed ID: 26481941
[TBL] [Abstract][Full Text] [Related]
14. Microemulsion based gel for topical dermal delivery of pseudolaric acid B: In vitro and in vivo evaluation.
Wan T; Xu T; Pan J; Qin M; Pan W; Zhang G; Wu Z; Wu C; Xu Y
Int J Pharm; 2015 Sep; 493(1-2):111-20. PubMed ID: 26216411
[TBL] [Abstract][Full Text] [Related]
15. Preparation, optimization, and evaluation of Zaltoprofen-loaded microemulsion and microemulsion-based gel for transdermal delivery.
Mishra R; Prabhavalkar KS; Bhatt LK
J Liposome Res; 2016 Dec; 26(4):297-306. PubMed ID: 26785055
[TBL] [Abstract][Full Text] [Related]
16. D-optimal experimental approach for designing topical microemulsion of itraconazole: Characterization and evaluation of antifungal efficacy against a standardized Tinea pedis infection model in Wistar rats.
Kumar N; Shishu
Eur J Pharm Sci; 2015 Jan; 67():97-112. PubMed ID: 25445834
[TBL] [Abstract][Full Text] [Related]
17. Nanocrystal-based gel of apremilast ameliorates imiquimod-induced psoriasis by suppressing inflammatory responses.
Parmar PK; Sharma N; Wasil Kabeer S; Rohit A; Bansal AK
Int J Pharm; 2022 Jun; 622():121873. PubMed ID: 35640806
[TBL] [Abstract][Full Text] [Related]
18. Phosphodiesterase 4 in inflammatory diseases: Effects of apremilast in psoriatic blood and in dermal myofibroblasts through the PDE4/CD271 complex.
Schafer PH; Truzzi F; Parton A; Wu L; Kosek J; Zhang LH; Horan G; Saltari A; Quadri M; Lotti R; Marconi A; Pincelli C
Cell Signal; 2016 Jul; 28(7):753-63. PubMed ID: 26806620
[TBL] [Abstract][Full Text] [Related]
19. An ionic liquid-in-water microemulsion as a potential carrier for topical delivery of poorly water soluble drug: Development, ex-vivo and in-vivo evaluation.
Goindi S; Kaur R; Kaur R
Int J Pharm; 2015 Nov; 495(2):913-23. PubMed ID: 26456294
[TBL] [Abstract][Full Text] [Related]
20. Amphotericin B topical microemulsion: formulation, characterization and evaluation.
Butani D; Yewale C; Misra A
Colloids Surf B Biointerfaces; 2014 Apr; 116():351-8. PubMed ID: 24521698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
